News Regeneron ends development of RSV antibody Regeneron dumps suptavumab after phase 3 trial failure.
News Mundipharma buys rights to CellAct cancer drug Drug will be progressed through phase 3 trials in biliary tract cancer.
News Ionis to file rare disease drug after GSK declines option Firm turns down options for inotersen and IONIS-FB-LRX.
News UK researchers trial new cancer immunotherapy The charity Cancer Research UK has joined with Biotecnol to begin early-stage clinical trials of a new kind of cancer immunotherapy in solid tumours, including lung cancers.
Views & Analysis Challenging antimicrobial drug resistance with calorimetry Tackling antimicrobial drug resistance with calorimetry.
News GW prepares for 2018 US launch of epilepsy drug But Zynerba's cannabis epilepsy drug fails in phase 2.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
